Bioxytran, Inc. is a BioPharma company whose mission is to develop anti-necrosis drugs that treat a
Location: United States, Massachusetts, Newton
Phone: +1 617-454-1199
Investors 1
| Date | Name | Website |
| - | TRITON FUN... | tritonfund... |
Mentions in press and media 5
| Date | Title | Description |
| 23.09.2024 | Bioxytran Pioneers New Era in Antiviral Treatment with Revolutionary Galectin-Targeting Drug | Prolectin-M Promises Breakthrough Results in Neutralizing Viruses, Including COVID-19 BOSTON, MA, UNITED STATES, September 23, 2024 /EINPresswire.com/ -- BIOXYTRAN, INC. (OTCQB: BIXT), a clinical-stage biotechnology company, has announced a... |
| 21.08.2024 | Bioxytran Measures the Presence of Carbon Monoxide When BXT-25 Delivers Oxygen to the Brain | British Journal Article Elucidates the Effects of Carbon Monoxide in Mitochondrial Activity Bioxytran Inc. (OTCQB:BIXT)BOSTON, MA, USA, August 21, 2024 /EINPresswire.com/ -- Bioxytran Inc. (the “Company”), a clinical stage biotechnology com... |
| 02.07.2024 | Bioxytran’s BXT-25 Drug Acts as a Universal Oxygen Carrier Like Hyperbaric Oxygenation for Stroke & Alzheimer’s Patients | Hyperbaric Oxygenation Mitochondrial Activity and Brain Physiological Functions BXT-25 is expected to oxygenate the brain and be monitored by Bioxytran’s FDA approved medical device to trace all oxygen molecules Bioxytran Inc. (OTCQB:BIXT)B... |
| 06.03.2024 | Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist | - |
| 15.08.2022 | Bioxytran Interview at the Emerging Growth Conference | Bioxytran, Inc. (OTCMKTS:BIXT)NEEDHAM, MA, USA, August 15, 2022 /EINPresswire.com/ -- BIOXYTRAN, INC. (Symbol: BIXT) (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral causing dis... |